1. Transcriptome profiling reveals distinct alterations in the B-cell signature and dysregulation of peripheral B-cell subsets in sickle cell anemia patients.
- Author
-
Felício RFM, Jarduli-Maciel LR, Mosella MQS, Almeida FC, de Lima KC, de Azevedo JTC, Gardinassi LG, Ramos PIP, de Santis GC, Silva-Pinto AC, de Castro FA, Oliveira MC, and Malmegrim KCR
- Subjects
- Humans, Male, Female, Adult, B-Lymphocytes metabolism, B-Lymphocytes immunology, B-Lymphocytes pathology, Adolescent, Middle Aged, Anemia, Sickle Cell genetics, Anemia, Sickle Cell blood, Anemia, Sickle Cell immunology, Gene Expression Profiling, B-Lymphocyte Subsets immunology, B-Lymphocyte Subsets metabolism, Transcriptome
- Abstract
Sickle cell anemia (SCA) is characterized by immune system activation and heightened susceptibility to infections. We hypothesized that SCA patients exhibit transcriptional alterations in B-cell-related genes, impacting their peripheral B-cell compartment and leading to dysregulated humoral immunity and increased infection susceptibility. Our objective was to conduct an in silico analysis of whole blood transcriptomes from SCA patients and healthy controls obtained from public repositories. We aimed to identify alterations in the adaptive immune system and validate these findings in our own SCA patient cohort. Bioinformatic analyses unveiled significant transcriptional alterations in B-cell signatures, developmental pathways, and signaling pathways. These results were validated in peripheral blood mononuclear cells from our SCA patient cohort and controls using real-time polymerase chain reaction and flow cytometry. Ninety genes exhibited differential expression, with 70 upregulated and 20 downregulated. Dysregulation in the B-cell compartment of SCA patients was evident, characterized by increased frequencies of immature and naive B-cells, and decreased percentages of memory B-cell subsets compared with healthy controls. Our findings highlight previously unexplored transcriptional and quantitative alterations in peripheral B-cells among SCA patients. Understanding these changes sheds light on the mechanisms contributing to the heightened infection risk in this population. Future studies should delve deeper into these molecular changes to develop targeted interventions and therapeutic strategies aimed at mitigating infection susceptibility in individuals with SCA., Competing Interests: Conflicts of Interest Disclosure The authors have nothing to disclose., (Copyright © 2024 International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF